The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | Equity | g01767105 | 4,335 | 78,000 | SH | SOLE | 78,000 | 0 | 0 | ||
| AMGEN INC | Equity | 031162100 | 4,533 | 31,000 | SH | SOLE | 31,000 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | Equity | 04033A100 | 10,574 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| ATHENAHEALTH INC | Equity | 04685W103 | 4,312 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
| BIO-RAD LABORATORIES-A | Equity | 090572207 | 8,932 | 49,000 | SH | SOLE | 49,000 | 0 | 0 | ||
| BSX US 02/17/17 C19 | Listed Option | 101137107 | 635 | 2,200 | SH | SOLE | 2,200 | 0 | 0 | ||
| CORIUM INTERNATIONAL INC | Equity | 21887L107 | 2,993 | 737,242 | SH | SOLE | 737,242 | 0 | 0 | ||
| CARDIOME PHARMA CORP | Equity | 14159U301 | 5,037 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | Equity | 375558103 | 7,161 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| HOLOGIC INC | Equity | 436440101 | 9,228 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| HSIC US 01/20/17 P155 | Listed Option | 806407102 | 164 | 360 | SH | SOLE | 360 | 0 | 0 | ||
| IMPAX LABORATORIES INC | Equity | 45256B101 | 3,412 | 257,500 | SH | SOLE | 257,500 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS PLC | Equity | G50871105 | 8,395 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | ||
| LABORATORY CRP OF AMER HLDGS | Equity | 50540R409 | 6,547 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| LUMINEX CORP | Equity | 55027E102 | 2,731 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| ALLSCRIPTS HEALTHCARE SOLUTI | Equity | 01988P108 | 7,811 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
| NOVOCURE LTD | Equity | G6674U908 | 6,476 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
| NXSTAGE MEDICAL INC | Equity | 67072V103 | 9,637 | 367,690 | SH | SOLE | 367,690 | 0 | 0 | ||
| OBALON THERAPEUTICS INC | Equity | 67424L100 | 4,979 | 562,606 | SH | SOLE | 562,606 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | Equity | 695127100 | 8,818 | 273,000 | SH | SOLE | 273,000 | 0 | 0 | ||
| QUOTIENT LTD | Equity | G73268107 | 484 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| SERVICE CORP INTERNATIONAL | Equity | 817565104 | 3,550 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| SPECTRANETICS CORP | Equity | 84760C107 | 8,075 | 329,600 | SH | SOLE | 329,600 | 0 | 0 | ||
| STERIS PLC | Equity | 859152100 | 4,246 | 63,000 | SH | SOLE | 63,000 | 0 | 0 | ||
| STREAMLINE HEALTH SOLUTIONS | Equity | 86323X106 | 1,423 | 1,138,000 | SH | SOLE | 1,138,000 | 0 | 0 | ||
| SYK US 01/20/17 P115 | Listed Option | 863667101 | 27 | 250 | SH | SOLE | 250 | 0 | 0 | ||
| TELADOC INC | Equity | 87918A105 | 6,857 | 415,600 | SH | SOLE | 415,600 | 0 | 0 | ||